Ronald E. White - Concepedia

Author

Ronald E. White

Also Known As

R E White, R. E. WHITE, R. E. White, R. White, R.E. White, RONALD E. WHITE, Ronald E White, Ronald E. White, Ronald White

Publications

5.2K

Citations

H-Index

Concepts

All Affiliations

UConn Health University of Michigan Bristol-Myers Squibb (United States)AIL Research (United States)Bristol-Myers Squibb (Germany)

About

Ronald E. White is an author at UConn Health specializing in medicine, biochemistry, and pharmacology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	18	28	2K
2	Natural Sciences	14	20	2K
3	Engineering	6	6	250
4	Health Sciences	1	1	10
5	Allergy	1	1	41

Ronald E. White

Publications

3.6K

Citations

H-Index

Page 1

	Year	Citations
Aliphatic hydroxylation by highly purified liver microsomal cytochrome P-450. Evidence for a carbon radical intermediate John T. Groves, Gary A. McClusky, Ronald E. White, Biochemical and Biophysical Research Communications Aliphatic HydroxylationAldehyde DehydrogenaseBiochemistryMedicineLiver Physiology	1978	537
Studies on hydroperoxide-dependent substrate hydroxylation by purified liver microsomal cytochrome P-450 Gerald D. Nordblom, Ronald E. White, Minor J. Coon Archives of Biochemistry and Biophysics BiochemistryMedicineLiver PhysiologyNatural SciencesHepatotoxicity	1976	340
Discovery of (1 <i>R</i> ,5 <i>S</i> )- <i>N</i> -[3-Amino-1-(cyclobutylmethyl)-2,3-dioxopropyl]- 3-[2( <i>S</i> )-[[[(1,1-dimethylethyl)amino]carbonyl]amino]-3,3-dimethyl-1-oxobutyl]- 6,6-dimethyl-3-azabicyclo[3.1.0]hexan-2( <i>S</i> )-carboxamide (SCH 503034), a Selective, Potent, Orally Bioavailable Hepatitis C Virus NS3 Protease Inhibitor: A Potential Therapeutic Agent for the Treatment of Hepatitis C Infection Srikanth Venkatraman, Stéphane Bogen, Ashok Arasappan, Journal of Medicinal Chemistry	2006	278
A three‐dimensional model of aromatase cytochrome P450 Sandra E. Graham-Lorence, Julian A. Peterson, Bilal Amarneh, Protein Science	1995	207
Cassette‐accelerated rapid rat screen: a systematic procedure for the dosing and liquid chromatography/atmospheric pressure ionization tandem mass spectrometric analysis of new chemical entities as part of new drug discovery Walter A. Korfmacher, Kathleen Cox, Kwokei Ng, Rapid Communications in Mass Spectrometry	2001	151
Functional differences between peroxidase compound I and the cytochrome P-450 reactive oxygen intermediate. Mary-Beth McCarthy, Ronald E. White Journal of Biological Chemistry Bioorganic ChemistryLipid PeroxidationPeroxidase CompoundRedox BiologyOxidative Stress	1983	145
Regioselectivity in the cytochromes P-450: Control by protein constraints and by chemical reactivities Ronald E. White, Mary-Beth McCarthy, Karen D. Egeberg, Archives of Biochemistry and Biophysics Chemical ReactivitiesBiochemistryNatural SciencesProtein ConstraintsEnzyme Catalysis	1984	142
Stereochemical dynamics of aliphatic hydroxylation by cytochrome P-450 Ronald E. White, J. Philip Miller, Leonard Favreau, Journal of the American Chemical Society Bioorganic ChemistryEngineeringChemical AnalysisAltmetric Attention ScoreOrganic Chemistry	1986	140
Development of a Novel in Vitro Model to Predict Hepatic Clearance Using Fresh, Cryopreserved, and Sandwich-Cultured Hepatocytes Yau Yi Lau, Elpida Sapidou, Xiaoming Cui, Drug Metabolism and Disposition	2002	130
Evidence for a homolytic mechanism of peroxide oxygen–oxygen bond cleavage during substrate hydroxylation by cytochrome P-450. Ronald E. White, Stephen G. Sligar, Minor J. Coon Journal of Biological Chemistry Redox SignalingSubstrate HydroxylationBiochemistryMedicineNatural Sciences	1980	125

Page 1